Chimaerins:new receptors for DIACYGLY & phorbol esters
嵌合蛋白:二酰甘氨酸的新受体
基本信息
- 批准号:7060526
- 负责人:
- 金额:$ 32.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-09-30 至 2008-04-30
- 项目状态:已结题
- 来源:
- 关键词:3T3 cellsHeLa cellsSDS polyacrylamide gel electrophoresisactinsathymic mousebiological signal transductionconfocal scanning microscopydiacylglycerolsenzyme activityfluorescence microscopygrowth factor receptorsguanosinetriphosphatase activating proteinimmunoprecipitationisozymesmetastasisneoplastic transformationphorbolsprotein isoformsprotein localizationprotein protein interactionprotein structure functionprotein transportreceptor expressionwestern blottingsyeast two hybrid system
项目摘要
DESCRIPTION (provided by applicant): It is well established that the phorbol esters, natural tumor promoters that mimic the actions of the lipid second messenger diacylglycerol (DAG), activate protein kinase C (PKC), a family of serine-threonine kinases that play important roles in multistage carcinogenesis. The traditional view of PKC as the sole receptor for the phorbol esters has been challenged by the discovery of proteins unrelated to PKC, which have a C1 domain, the phorbol ester binding site in PKC. Indeed, we have established that "chimaerins", a family of proteins with homology to Rac GAPs (GTPase Activating Proteins) are high affinity receptors for phorbol esters and DAG. Moreover, like PKCs, the beta2-chimaerin isoform is subject to translocation by phorbol esters in a PKC-independent fashion. Importantly, we found that beta2-chimaerin accelerates GTP hydrolysis from Rac1, leading to the inactivation of this GTPase. The central hypothesis of this competing renewal is that chimaerin activation by phorbol ester/DAG will impair Rac-mediated signaling and functions. In Specific Aim 1 we will explore the complex interrelationship between DAG generation by growth factors, chimaerin translocation and Rac-GTP levels. We predict that translocation of chimaerins to the plasma membrane through its C1 domain will result in the activation of chimaerin Rac-GAP activity and Rac inactivation. In Specific Aim 2 we will investigate how protein-protein interactions regulate chimaerin function, following analogous models to those described for PKC isozymes. We have isolated several chimaerin interacting proteins that play important roles in controlling intracellular localization and function of chimaerins. A second aspect of this aim will involve the characterization of phosphotyrosine proteins isolated in our laboratory that may associate to the beta2-chimaerin SH2 domain. In Specific Aim 3 we will focus on the roles of chimaerin isoforms in mitogenic signaling. Since Rac has a central role in the control of mitogenicity, our hypothesis is that chimaerins, by inhibiting Rac function, will impair mitogenic signaling and proliferation. Since Rac is critical for actin cytoskeletal reorganization, Specific Aim 4 will explore if chimaerins regulate key steps of the metastatic cascade, including filament actin membrane structures, cell spreading, migration and invasion. Our research has the potential for delineating novel PKC-independent pathways for the phorbol esters and DAG and their relationship to proliferation, malignant transformation, and metastasis. More importantly, our research challenges the use of phorbol esters as selective PKC activators in cells.
描述(由申请人提供):已充分确定佛波醇酯(模拟脂质第二信使甘油二酯(DAG)作用的天然肿瘤促进剂)激活蛋白激酶C(PKC),一种在多阶段致癌作用中发挥重要作用的丝氨酸-苏氨酸激酶家族。PKC作为佛波醇酯的唯一受体的传统观点受到了与PKC无关的蛋白质的发现的挑战,这些蛋白质具有C1结构域,即PKC中的佛波醇酯结合位点。事实上,我们已经确定了“嵌合蛋白”,一个与Rac GAP(GTP酶激活蛋白)具有同源性的蛋白质家族,是佛波酯和DAG的高亲和力受体。此外,与PKC一样,β 2-嵌合蛋白同种型以PKC非依赖性方式受到佛波酯的易位。重要的是,我们发现β 2-chimaerin加速Rac 1的GTP水解,导致这种GTP酶失活。这种竞争性更新的中心假设是,通过佛波酯/DAG激活嵌合蛋白将损害Rac介导的信号传导和功能。在具体目标1中,我们将探讨DAG生成的生长因子,嵌合体易位和Rac-GTP水平之间的复杂的相互关系。我们预测,嵌合蛋白易位到质膜通过其C1结构域将导致嵌合蛋白Rac-GAP活性的激活和Rac失活。在具体目标2中,我们将研究蛋白质-蛋白质相互作用如何调节嵌合蛋白的功能,以下类似的模型PKC同工酶。我们已经分离出几个嵌合蛋白相互作用的蛋白质,发挥重要作用,在控制细胞内的定位和功能的嵌合蛋白。这个目标的第二个方面将涉及在我们的实验室中分离的磷酸酪氨酸蛋白的表征,可能与β 2-嵌合蛋白SH 2结构域。在具体目标3中,我们将重点关注嵌合蛋白亚型在促有丝分裂信号传导中的作用。由于Rac在有丝分裂原性的控制中具有核心作用,我们的假设是嵌合蛋白通过抑制Rac功能,将损害有丝分裂信号传导和增殖。由于Rac对肌动蛋白细胞骨架重组至关重要,因此Specific Aim 4将探索嵌合蛋白是否调节转移级联的关键步骤,包括微丝肌动蛋白膜结构,细胞扩散,迁移和侵袭。我们的研究有可能为佛波醇酯和DAG及其与增殖、恶性转化和转移的关系描绘新的PKC非依赖性途径。更重要的是,我们的研究挑战了佛波醇酯作为细胞中选择性PKC激活剂的用途。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARCELO G. KAZANIETZ其他文献
MARCELO G. KAZANIETZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARCELO G. KAZANIETZ', 18)}}的其他基金
Protein kinase C signaling in prostate cancer health disparities
前列腺癌健康差异中的蛋白激酶 C 信号传导
- 批准号:
10744533 - 财政年份:2023
- 资助金额:
$ 32.74万 - 项目类别:
Effectors of protein kinase C-mediated tumor progression
蛋白激酶 C 介导的肿瘤进展的效应器
- 批准号:
10543367 - 财政年份:2022
- 资助金额:
$ 32.74万 - 项目类别:
Rac guanine nucleotide exchange factors in lung cancer
肺癌中的 Rac 鸟嘌呤核苷酸交换因子
- 批准号:
10522390 - 财政年份:2022
- 资助金额:
$ 32.74万 - 项目类别:
Rac guanine nucleotide exchange factors in lung cancer
肺癌中的 Rac 鸟嘌呤核苷酸交换因子
- 批准号:
10674846 - 财政年份:2022
- 资助金额:
$ 32.74万 - 项目类别:
Effectors of protein kinase C-mediated tumor progression
蛋白激酶 C 介导的肿瘤进展的效应器
- 批准号:
9198206 - 财政年份:2016
- 资助金额:
$ 32.74万 - 项目类别:
Effectors of protein kinase C-mediated tumor progression
蛋白激酶 C 介导的肿瘤进展的效应器
- 批准号:
9042748 - 财政年份:2016
- 资助金额:
$ 32.74万 - 项目类别:
CXCL13: a mediator of prostate cancer progression
CXCL13:前列腺癌进展的介质
- 批准号:
9256445 - 财政年份:2015
- 资助金额:
$ 32.74万 - 项目类别:
ErbB receptor signaling via small G-proteins in breast cancer
乳腺癌中通过小 G 蛋白进行的 ErbB 受体信号传导
- 批准号:
8468659 - 财政年份:2010
- 资助金额:
$ 32.74万 - 项目类别:
ErbB receptor signaling via small G-proteins in breast cancer
乳腺癌中通过小 G 蛋白进行的 ErbB 受体信号传导
- 批准号:
8607903 - 财政年份:2010
- 资助金额:
$ 32.74万 - 项目类别:
相似海外基金
Temporal and spatial localization of TRAPP subunits during the cell cycle of HeLa cells
HeLa 细胞细胞周期中 TRAPP 亚基的时空定位
- 批准号:
432807-2012 - 财政年份:2012
- 资助金额:
$ 32.74万 - 项目类别:
University Undergraduate Student Research Awards
Analysis of the regulation of asymmetric cell division by using the artificially induced polarization of HeLa cells.
利用HeLa细胞的人工诱导极化分析不对称细胞分裂的调控。
- 批准号:
24657088 - 财政年份:2012
- 资助金额:
$ 32.74万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
The internalization mechanism of Ureaplasma parvum in HeLa cells.
小脲原体在 HeLa 细胞中的内化机制。
- 批准号:
23791241 - 财政年份:2011
- 资助金额:
$ 32.74万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
MicroRNA analysis of cervical cancer HeLa cells resistant to gene silencing of human papillomavirus (HPV) E6 and E7 onco
宫颈癌 HeLa 细胞对人乳头瘤病毒 (HPV) E6 和 E7 基因沉默具有抗性的 MicroRNA 分析
- 批准号:
nhmrc : 519809 - 财政年份:2008
- 资助金额:
$ 32.74万 - 项目类别:
Early Career Fellowships
Identification and characterization of new genetic responses in escherichia coli and human (HeLa) cells
大肠杆菌和人类 (HeLa) 细胞中新遗传反应的鉴定和表征
- 批准号:
3222-2002 - 财政年份:2003
- 资助金额:
$ 32.74万 - 项目类别:
Discovery Grants Program - Individual
Identification and characterization of new genetic responses in escherichia coli and human (HeLa) cells
大肠杆菌和人类 (HeLa) 细胞中新遗传反应的鉴定和表征
- 批准号:
3222-2002 - 财政年份:2002
- 资助金额:
$ 32.74万 - 项目类别:
Discovery Grants Program - Individual
Identification and characterization of new genetic responses ub escgerucgua ciku abd gynab (HeLa) cells
新遗传反应 ub escgerucgua ciku abd gynab (HeLa) 细胞的鉴定和表征
- 批准号:
3222-1998 - 财政年份:2001
- 资助金额:
$ 32.74万 - 项目类别:
Discovery Grants Program - Individual
Identification and characterization of new genetic responses ub escgerucgua ciku abd gynab (HeLa) cells
新遗传反应 ub escgerucgua ciku abd gynab (HeLa) 细胞的鉴定和表征
- 批准号:
3222-1998 - 财政年份:2000
- 资助金额:
$ 32.74万 - 项目类别:
Discovery Grants Program - Individual
Identification and characterization of new genetic responses ub escgerucgua ciku abd gynab (HeLa) cells
新遗传反应 ub escgerucgua ciku abd gynab (HeLa) 细胞的鉴定和表征
- 批准号:
3222-1998 - 财政年份:1999
- 资助金额:
$ 32.74万 - 项目类别:
Discovery Grants Program - Individual
Identification and characterization of new genetic responses ub escgerucgua ciku abd gynab (HeLa) cells
新遗传反应 ub escgerucgua ciku abd gynab (HeLa) 细胞的鉴定和表征
- 批准号:
3222-1998 - 财政年份:1998
- 资助金额:
$ 32.74万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




